These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 32311762)
21. SARS-CoV-2, the Virus that Causes COVID-19: Cytometry and the New Challenge for Global Health. Cossarizza A; De Biasi S; Guaraldi G; Girardis M; Mussini C; Cytometry A; 2020 Apr; 97(4):340-343. PubMed ID: 32187834 [No Abstract] [Full Text] [Related]
22. COVID-19: The race for a vaccine. Lockey E J Renin Angiotensin Aldosterone Syst; 2020; 21(2):1470320320926902. PubMed ID: 32404020 [No Abstract] [Full Text] [Related]
23. More bricks in the wall against SARS-CoV-2 infection: involvement of γ9δ2 T cells. Rijkers G; Vervenne T; van der Pol P Cell Mol Immunol; 2020 Jul; 17(7):771-772. PubMed ID: 32467616 [No Abstract] [Full Text] [Related]
24. Atypical lymphocyte morphology in SARS-CoV-2 infection. El Jamal SM; Salib C; Stock A; Uriarte-Haparnas NI; Glicksberg BS; Teruya-Feldstein J; Dembitzer FR; Nadkarni GN; Firpo-Betancourt A Pathol Res Pract; 2020 Sep; 216(9):153063. PubMed ID: 32825937 [No Abstract] [Full Text] [Related]
25. Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019. Kowitdamrong E; Puthanakit T; Jantarabenjakul W; Prompetchara E; Suchartlikitwong P; Putcharoen O; Hirankarn N PLoS One; 2020; 15(10):e0240502. PubMed ID: 33035234 [TBL] [Abstract][Full Text] [Related]
27. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074 [TBL] [Abstract][Full Text] [Related]
28. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports"). Persad G; Emanuel EJ JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357 [No Abstract] [Full Text] [Related]
29. The paramount importance of serological surveys of SARS-CoV-2 infection and immunity. Goudsmit J Eur J Epidemiol; 2020 Apr; 35(4):331-333. PubMed ID: 32318914 [No Abstract] [Full Text] [Related]
30. Optimizing Administration of CAR T-Cell Therapy During the COVID-19 Pandemic. Bishop MR Clin Adv Hematol Oncol; 2020 Jul; 18(7):400-403. PubMed ID: 32903251 [No Abstract] [Full Text] [Related]
31. Airborne Particulate Matter and SARS-CoV-2 Partnership: Virus Hitchhiking, Stabilization and Immune Cell Targeting - A Hypothesis. Farhangrazi ZS; Sancini G; Hunter AC; Moghimi SM Front Immunol; 2020; 11():579352. PubMed ID: 33072124 [No Abstract] [Full Text] [Related]
32. Cytokine storm and immunomodulatory therapy in COVID-19: Role of chloroquine and anti-IL-6 monoclonal antibodies. Zhao M Int J Antimicrob Agents; 2020 Jun; 55(6):105982. PubMed ID: 32305588 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 and post-traumatic stress disorder: A vicious circle involving immunosuppression. Liang X; Zhu Y; Fang Y CNS Neurosci Ther; 2020 Aug; 26(8):876-878. PubMed ID: 32678521 [No Abstract] [Full Text] [Related]
34. A possible role for B cells in COVID-19? Lesson from patients with agammaglobulinemia. Quinti I; Lougaris V; Milito C; Cinetto F; Pecoraro A; Mezzaroma I; Mastroianni CM; Turriziani O; Bondioni MP; Filippini M; Soresina A; Spadaro G; Agostini C; Carsetti R; Plebani A J Allergy Clin Immunol; 2020 Jul; 146(1):211-213.e4. PubMed ID: 32333914 [No Abstract] [Full Text] [Related]
36. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Gaebler C; Nussenzweig MC Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943 [No Abstract] [Full Text] [Related]
37. Cellular immune responses to covid-19. Sewell HF; Agius RM; Stewart M; Kendrick D BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031 [No Abstract] [Full Text] [Related]